Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(71.4%)
Phase 4
2(28.6%)
7Total
N/A(5)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT07195903Not ApplicableRecruiting

The STAND-UP Study

Role: lead

NCT05129228Not ApplicableRecruiting

Optical Coherence Tomography of the Saphenous Vein Graft

Role: lead

NCT04621461Phase 4Completed

Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting

Role: lead

NCT04370782Phase 4Completed

Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting

Role: lead

NCT01078272Not ApplicableTerminated

The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)

Role: lead

NCT04038944Unknown

Anticoagulant and Antiarrhythmic Management Based on Continuous Rhythm Monitoring

Role: lead

NCT03581032Unknown

Optimization of Cardiac Pacing Using CardioMEMS

Role: lead

NCT03106961Unknown

OCT and Scaffold Embedding After NC Balloon

Role: lead

NCT02671123Not ApplicableUnknown

Does Co-registration of OCT and Angiography Reduce Geographic Miss of Stent Implantation?

Role: lead

NCT01103843Not ApplicableUnknown

Plavix, Prasugrel and Drug Eluting Stents Pilot Trial

Role: lead

All 10 trials loaded